204 related articles for article (PubMed ID: 32079950)
1. Commercial Interests in Continuing Medical Education: Where Do Electronic Health Record Vendors Fit?
Rubinstein PF; Middleton B; Goodman KW; Lehmann CU
Acad Med; 2020 Nov; 95(11):1674-1678. PubMed ID: 32079950
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
Brody H
J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
[TBL] [Abstract][Full Text] [Related]
3. The uncertain future of continuing medical education: commercialism and shifts in funding.
Van Harrison R
J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
[TBL] [Abstract][Full Text] [Related]
4. It is time to study the costs and benefits of regulating continuing medical education in the United States.
Mazmanian PE
J Contin Educ Health Prof; 2009; 29(4):197-200. PubMed ID: 19998479
[TBL] [Abstract][Full Text] [Related]
5. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
Mazmanian PE
J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
[TBL] [Abstract][Full Text] [Related]
6. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
7. Medical education and communication companies involved in CME: an updated profile.
Peterson ED; Overstreet KM; Parochka JN; Lemon MR
J Contin Educ Health Prof; 2008; 28(4):205-13, quiz 213-9. PubMed ID: 19058242
[TBL] [Abstract][Full Text] [Related]
8. A risk stratification tool to assess commercial influences on continuing medical education.
Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
[TBL] [Abstract][Full Text] [Related]
9. [Comparative evaluation of sponsored and unsponsored continuing medical education].
Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
[TBL] [Abstract][Full Text] [Related]
10. Accreditation for learning and change: quality and improvement as the outcome.
Regnier K; Kopelow M; Lane D; Alden E
J Contin Educ Health Prof; 2005; 25(3):174-82. PubMed ID: 16173052
[TBL] [Abstract][Full Text] [Related]
11. Commercial support and continuing medical education.
Steinbrook R
N Engl J Med; 2005 Feb; 352(6):534-5. PubMed ID: 15703417
[No Abstract] [Full Text] [Related]
12. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
Lichter PR
Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Continuing Medical Education at U.S. Medical Schools and Other Accredited Organizations: A 20-Year Analysis.
Rayburn WF; Regnier K; McMahon GT
Acad Med; 2020 Apr; 95(4):623-628. PubMed ID: 31626001
[TBL] [Abstract][Full Text] [Related]
14. [Conflict of interest in continuing medical education - Studies on certified CME courses].
Lenzen LM; Weidringer JW; Ollenschläger G
Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
[TBL] [Abstract][Full Text] [Related]
15. The medical-industrial complex, professional medical associations, and continuing medical education.
Schofferman J
Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
[TBL] [Abstract][Full Text] [Related]
16. Conflict of interest.
Richard Conti C
Clin Cardiol; 2009 Dec; 32(12):666-7. PubMed ID: 20027665
[TBL] [Abstract][Full Text] [Related]
17. The effect of industry support on participants' perceptions of bias in continuing medical education.
Kawczak S; Carey W; Lopez R; Jackman D
Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
Rosner F
Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
[TBL] [Abstract][Full Text] [Related]
19. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE
Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526
[TBL] [Abstract][Full Text] [Related]
20. Low rates of reporting commercial bias by physicians following online continuing medical education activities.
Ellison JA; Hennekens CH; Wang J; Lundberg GD; Sulkes D
Am J Med; 2009 Sep; 122(9):875-8. PubMed ID: 19699386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
